Biotechnology News

Mon, 2014-01-27 20:00

BILLERICA, Mass.--(BUSINESS WIRE)--Belmont enters Japanese market.

Mon, 2014-01-27 20:00

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2013 financial results and provide 2014 financial guidance on Tuesday, February 11th, after the market closes...

Mon, 2014-01-27 20:00

WASHINGTON--(BUSINESS WIRE)--BIO announces registration for the newly improved 2014 BIO International Convention® is now open. This year’s event will be held June 23-26, 2014 at the San Diego Convention Center in San Diego, CA.

Mon, 2014-01-27 16:00

KENNESAW, Ga.--(BUSINESS WIRE)--FOB Synthesis, Inc. has entered into a research and development option and license agreement with AstraZeneca for the development of a novel antibiotic to treat drug-resistant bacterial infections. The treatment...

Mon, 2014-01-27 16:00

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet...

Mon, 2014-01-27 16:00

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Bina Technologies, the genomic big data science company accelerating personalized medicine, today announced the expansion of their advisory board and commercial team.

Mon, 2014-01-27 16:00

PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard establishes three-year, no-minimum-draw Standby Equity Facility (PACEO®) with Société Générale

Mon, 2014-01-27 12:01

EAGAN, Minn.--(BUSINESS WIRE)--Peter J. Maimonis, Ph.D. joins Biothera as Vice President of Biomarker Development to help advance the science of the predictive biomarker for Imprime PGG, the company's Ph 3 cancer immunotherapy drug

Mon, 2014-01-27 12:01

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation today announced that OncoCyte has initiated clinical development of its bladder cancer diagnostic test in both the United States and China. In...

Mon, 2014-01-27 12:01

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire from the company at the end of this year. The company anticipates...

Mon, 2014-01-27 12:01

ST. LOUIS--(BUSINESS WIRE)--Medivir AB selects D360 as its Global Drug Discovery Platform, will use D360 to deliver research data, analytic tools to its discovery chemists and biologists in Stockholm, Sweden, and Cambridge, UK.

Mon, 2014-01-27 12:01

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter/year-end 2013 financial results conference call for 8:30 a.m. ET on Wednesday, February 12, 2014. The schedules for the...

Mon, 2014-01-27 12:01

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., an agriculture technology company, is pleased to announce that nine sorghum growers who planted Chromatin’s Sorghum Partners™ brand products, won at the county, state and national level in the National...

Mon, 2014-01-27 12:01

WILMINGTON, Mass.--(BUSINESS WIRE)--Kapa Biosystems strengthens leadership team and relocates corporate and international headquarters to larger locations in Wilmington, Mass. and Cape Town, South Africa

Mon, 2014-01-27 12:01

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore launches feasibility study with first patient enrolled at the University of Michigan. Trial to look at the Gore TAG Thoracic Branch Endoprosthesis LSA.

Mon, 2014-01-27 12:01

WILMINGTON, N.C.--(BUSINESS WIRE)--AAIPharma and Cambridge Major, leading global providers of pharmaceutical development services, announce the appointment of Jeff Yuen as Executive Vice President, Global Quality.

Mon, 2014-01-27 12:01

MIAMI--(BUSINESS WIRE)--Bio-Tissue, the leader in regenerative tissue therapies for ocular surface disease, reports consistently high unit sales growth over last 7 years. New standard of care emerging as utilization grows.

Mon, 2014-01-27 12:01

HARLEYSVILLE, Pa.--(BUSINESS WIRE)--Colorcon has introduced Opadry NutraPure the first fully certified organic coating for dietary supplement tablets

Mon, 2014-01-27 12:01

NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--GenePeeks has been issued patent No. 8,620,594 for algorithms that simulate the genetic interactions occurring naturally in human reproduction in order to create hypothetical “digital babies.”

Mon, 2014-01-27 12:01

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. today announced an approximate one-quarter delay to the Company’s timeline for the resubmission of the new drug application (NDA) for Sustol® to the FDA.

Mon, 2014-01-27 12:01

GLASGOW, Scotland--(BUSINESS WIRE)--Collbio, a leading supplier of bovine collagen has acquired Collagen Solutions of San Jose and listed on the UK Aim stock exchange

Mon, 2014-01-27 09:00

BOULDER, Colo.--(BUSINESS WIRE)--CordenPharma Colorado announces their recent approval of the SafeBridge Potent Compound Safety Certification for the manufacturing of highly potent Active Pharmaceutical Ingredients (APIs).

Mon, 2014-01-27 09:00

LANGHORNE, Pa.--(BUSINESS WIRE)--Alliqua has been approved for trading on the NASDAQ Capital management, with trading expected to commence on January 28, 2014 under its current symbol ALQA.

Mon, 2014-01-27 09:00

BRAINTREE, Mass.--(BUSINESS WIRE)--Paragonix Technologies Inc., Announces Presentation of "Superior Donor Heart Preservation Using Hypothermic Oxygenated Perfusion" at CEOT Discussing the Sherpa Perfusion™ Cardiac Transport System

Mon, 2014-01-27 09:00

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (the “Company”) (Nasdaq:NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced the launch of...

Mon, 2014-01-27 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Editas Medicine, a transformative genome editing company, today announced new published research from company co-founder J. Keith Joung, M.D., Ph.D., demonstrating the ability of truncated guide RNAs (tru-gRNAs...

Mon, 2014-01-27 09:00

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (“Emergent”) (NYSE:EBS) announced today that the initial purchasers have exercised in full their option to purchase an additional $35 million principal amount of its 2.875% Convertible...

Mon, 2014-01-27 09:00

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) (“Forest Laboratories”) today announced a proposed offering of $1.8 billion aggregate principal amount of senior unsecured fixed rate notes in two tranches, with one tranche due 2019...

Mon, 2014-01-27 09:00

MINNEAPOLIS & TAMPA, Fla.--(BUSINESS WIRE)--Biovest International, Inc. (“Biovest”), a leader and a pioneer in the development of personalized cancer immunotherapies, today announced that Biovest’s Chief Executive Officer, Carlos F. Santos,...

Mon, 2014-01-27 09:00

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides Reports Construction of its New Facility and cGMP Pilot Production Plant is Nearing Completion, also Provides Details of its $20 Million Registered Direct Offering

Mon, 2014-01-27 06:00

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--RBCC Develops Innovations in White-Hot 3D Bioprinting Sector

Mon, 2014-01-27 02:02

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix Inc Ohio State Department of Economic Development International Trade Assistance Center and YSU assists in signing of distribution agreement with Saudi Arabian company

Mon, 2014-01-27 01:00

DUBAI, United Arab Emirates--(BUSINESS WIRE)--ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative...

Fri, 2014-01-24 19:00

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Announces Increase to Non-Brokered Private Placement.

Fri, 2014-01-24 19:00

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on January 24, 2014. This dividend is payable on May 9, 2014, to all shareholders...

Fri, 2014-01-24 16:00

MIAMI--(BUSINESS WIRE)--NextSource Biotechnology Announces FDA Short Supply release of Lomustine (CCNU), formally known as Bristol Myers Squibb (CeeNu®) Brand Oncology Product. Currently marketed by NextSource Biotechnology.

Fri, 2014-01-24 16:00

SOMERSET, N.J.--(BUSINESS WIRE)--CATALENT FILES REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING

Fri, 2014-01-24 15:00

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus's PV-10 Path to Initial Approval In U.S. Now Clear Per FDA Meeting Minutes

Fri, 2014-01-24 12:01

ATLANTA--(BUSINESS WIRE)--Holzer investigates Cleveland BioLabs

Fri, 2014-01-24 12:01

LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--Sirona (NASDAQ:SIRO), the dental technology leader, today announced that the Company will report its fiscal 2014 first quarter financial results on Friday, February 7th, 2014, before the opening of the U.S...

Fri, 2014-01-24 12:01

LEESBURG, Va.--(BUSINESS WIRE)--Today K2M celebrates 10 years of entrepreneurial success and embarks on its second decade of achievement.

Fri, 2014-01-24 12:01

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart leads post-acute care Meaningful Use Stage 2 EHR certification with ambulatory Complete EHR, 2014 Edition certification of TIER® version 8.0, the third Netsmart Stage 2-certified EHR.

Fri, 2014-01-24 12:01

TOKYO--(BUSINESS WIRE)--Bridge Report on R-Tech Ueno Issued: Strong First Half Earnings, Full Year FY3/14 Earnings Expected to Grow Strongly

Fri, 2014-01-24 12:01

CAMBRIDGE, Mass. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the...

Fri, 2014-01-24 12:01

JERUSALEM & LUND, Sweden--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development...

Fri, 2014-01-24 09:00

LOS ANGELES--(BUSINESS WIRE)--Lion Biotechnologies, Inc. (OTCQB: LBIO) announced that Chief Executive Officer Manish Singh, Ph.D., will preside over the introductory session of the Phacilitate Immunotherapy Forum on Monday, January 27, 2014....